Stoke Therapeutics STOK
NASDAQ STOK
$25.62 -0.39 (-1.50%)
At close: Oct 2, 2026 · 4:00 PM EDT

Stoke Therapeutics (STOK) Other Accumulated Expenses (2018 - 2026)

Updated

Stoke Therapeutics (STOK) posted Other Accumulated Expenses of $1.62 million for Q2 2026, down 7.5% from $1.75 million a year earlier but up 7.9% from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Other Accumulated Expenses (2018 - 2026) Analysis & Trends

At the end of FY2025, Stoke Therapeutics' Other Accumulated Expenses came in at $1.06 million, up 40.8% from FY2024.

  • Annual Other Accumulated Expenses shows a five-year compound annual growth rate of 18.2% (FY2020 to FY2025).
  • In prior years, Stoke Therapeutics' Other Accumulated Expenses was $753,000 in FY2024 (-12.1%), $857,000 in FY2023 (+68.4%), $509,000 in FY2022 (-5.7%) and $540,000 in FY2021 (+17.6%).
  • Quarterly Other Accumulated Expenses has run from a low of $328,000 in Q3 2021 to a high of $2.07 million in Q1 2025 over five years.
  • On a year-over-year basis, Other Accumulated Expenses increased in five of the last eight quarters, with growth averaging 29.2%.
  • The strongest year-over-year quarter for Other Accumulated Expenses in the past five years was Q1 2025, with growth of 111.6%; the weakest was Q1 2022, with a decline of 55.1%.
  • According to Business Quant data, Other Accumulated Expenses for the three prior quarters was $1.5 million (Q1 2026), $1.06 million (Q4 2025) and $795,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Stoke Therapeutics 1.60 Bn 429.41 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.62 Mn
Mar 31, 2026 1.50 Mn
Dec 31, 2025 1.06 Mn
Sep 30, 2025 795,000.00
Jun 30, 2025 1.75 Mn
Mar 31, 2025 2.07 Mn
Dec 31, 2024 753,000.00
Sep 30, 2024 597,000.00
Jun 30, 2024 1.04 Mn
Mar 31, 2024 980,000.00
Dec 31, 2023 857,000.00
Sep 30, 2023 472,000.00
Jun 30, 2023 703,000.00
Mar 31, 2023 506,000.00
Dec 31, 2022 509,000.00
Sep 30, 2022 426,000.00
Jun 30, 2022 750,000.00
Mar 31, 2022 523,000.00
Dec 31, 2021 540,000.00
Sep 30, 2021 328,000.00
API Access

Stoke Therapeutics Other Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=STOK&period=max&api_key=YOUR_API_KEY